BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes.
Peiffer L, Farahpour F, Sriram A, Spassova I, Hoffmann D, Kubat L, Stoitzner P, Gambichler T, Sucker A, Ugurel S, Schadendorf D, Becker JC.
Peiffer L, et al. Among authors: sriram a.
Cancer Immunol Immunother. 2021 Jun;70(6):1635-1647. doi: 10.1007/s00262-020-02804-4. Epub 2020 Dec 4.
Cancer Immunol Immunother. 2021.
PMID: 33275172
Free PMC article.